Keyword: Pharmaceuticals

News

Shire to Acquire Baxalta for $32 Billion

12.01.2016 - In a deal worth around $32 billion, Irish drug maker Shire – headquartered in Dublin but managed from Boston, Massachusetts – has agreed a takeover of US biopharmaceutical company...

News

Teva and Takeda in Japanese Generics JV

01.12.2015 - Israeli generics giant Teva and Japanese drugmaker Takeda have agreed to form a partnership to address the growing importance of generics in Japan. The 51:49 joint venture, which...

News

Pfizer to Buy Allergan for $160 Billion

24.11.2015 - Confirming rumors of the past weekend, US pharmaceutical giant Pfizer has said it will buy drugmaker Allergan for $160 million and move its headquarters to Ireland. The ever faster...

News

Eli Lilly Expands R&D at Indianapolis

05.11.2015 - US drugmaker Eli Lilly plans to expand its research and development headquarters in Indianapolis, Indiana, to the tune of $70 million, adding floor space and a new disciplinary...

News

Shire to Buy Biotech Firm Dyax

04.11.2015 - Ireland-based and London-listed drugmaker Shire has agreed what is being called a “defensive” deal to buy US biotech firm Dyax, which has a breakthrough drug said to threaten one...

News

Evonik Starts Expanded Silica Plant in Japan

30.10.2015 - Evonik has started up its newly expanded production facilities for specialty silicas at Ako, Japan. The investment will increase by half capacity at the site of DSL, the German...

News

Pfizer and Allergan in Merger Talks

30.10.2015 - US pharmaceutical giant Pfizer and Ireland-domiciled former US drugmaker Allergan (in its current incarnation a combined Allergan and Actavis) have confirmed they are in “friendly”...

Markets & Companies

Overcoming USA Sales Resistance

28.10.2015 - It is estimated that more than 60% of German companies attempting USA market penetration, subsequently fail and withdraw from the market. Europeans often incorrectly attribute this...